Actionnariat et activité des initiés pour ACADIA Pharmaceuticals Inc. (ACAD): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $27.54 |
| Capitalisation | $4.7B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-06 | Schneyer Mark C. | M-Exempt | 14,292 | $255K |
| 2026-08-06 | Schneyer Mark C. | S-Sale | 5,000 | $145K |
| 2026-08-05 | Schneyer Mark C. | M-Exempt | 5,849 | $104K |
| 2026-08-05 | Schneyer Mark C. | M-Exempt | 5,849 | $104K |
| 2026-08-06 | Schneyer Mark C. | S-Sale | 9,292 | $273K |
| 2026-08-05 | Schneyer Mark C. | S-Sale | 5,849 | $170K |
| 2026-08-06 | Schneyer Mark C. | M-Exempt | 14,292 | $255K |
| 2026-07-29 | Thompson Elizabeth H.Z. | M-Exempt | 32,272 | |
| 2026-07-29 | Thompson Elizabeth H.Z. | M-Exempt | 32,272 | |
| 2026-07-30 | Thompson Elizabeth H.Z. | S-Sale | 16,508 | $431K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $163.6M | $69.4M | $134.8M | $189.7M | $326.0M | $147.4M | $114.8M | $188.7M | $319.6M | $177.7M |
| Placements à Court Terme | $365.4M | $271.9M | $338.8M | $507.7M | $305.9M | $373.3M | $302.0M | $250.2M | $436.4M | $642.0M |
| Créances | $7.1M | $18.4M | $27.8M | $37.9M | $50.3M | $65.3M | $63.1M | $102.3M | $104.7M | $148.2M |
| Stocks | $4.2M | $5.2M | $4.1M | $6.3M | $9.7M | $7.9M | $6.6M | $35.8M | $21.9M | $34.7M |
| Actifs Courants | $547.9M | $373.5M | $526.1M | $760.2M | $717.6M | $617.8M | $507.9M | $616.1M | $938.3M | $1.06B |
| Immobilisations Corporelles | $3.1M | $2.7M | $3.3M | $12.7M | $56.4M | $66.3M | $61.6M | $56.5M | $50.8M | $54.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $7.0M | $5.5M | $4.1M | $2.6M | $1.1M | 0 | 0 | $65.5M | $119.8M | $108.9M |
| Actifs Totaux | $561.2M | $384.5M | $540.2M | $783.2M | $782.6M | $700.1M | $587.8M | $749.0M | $1.19B | $1.56B |
| Dettes Fournisseurs | $3.9M | $8.8M | $3.2M | $7.2M | $8.5M | $6.9M | $12.7M | $17.5M | $16.2M | $10.9M |
| Dette à Court Terme | 0 | 0 | 0 | $3.4M | $5.1M | 0 | 0 | $9.4M | 0 | $11.6M |
| Passifs Courants | $42.6M | $49.0M | $59.6M | $74.8M | $106.0M | $96.1M | $125.6M | $254.3M | $394.9M | $277.1M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $42.7M | $49.2M | $61.1M | $84.0M | $155.6M | $159.2M | $187.4M | $317.2M | $455.0M | $336.8M |
| Réserves | -$934.0M | -$1.22B | -$1.47B | -$1.70B | -$1.99B | -$2.15B | -$2.37B | -$2.43B | -$2.20B | -$1.81B |
| Capitaux Propres | $518.4M | $335.3M | $479.1M | $699.1M | $627.0M | $540.9M | $400.4M | $431.8M | $732.8M | $1.23B |
| Dette Totale | 0 | 0 | 0 | $9.8M | $49.5M | $64.4M | $62.0M | $57.2M | $52.0M | $52.2M |
| Dette Nette | -$529.0M | -$341.3M | -$473.5M | -$687.6M | -$582.4M | -$456.3M | -$354.8M | -$381.7M | -$704.0M | -$767.5M |
| Fonds de Roulement | $505.3M | $324.4M | $466.5M | $685.4M | $611.6M | $521.8M | $382.3M | $361.9M | $543.4M | $785.0M |
Santé financière
| Dette / Capitaux propres | 0.06 |
| Ratio de liquidité | 3.39 |
Rentabilité
| Marge brute | 91.13% |
| Marge opérationnelle | 7.59% |
| Marge nette | 33.42% |
Entreprises liées: ADMA · BLTE · CRNX · DYN · IMVT · LGND · MIRM
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ACAD: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions